Emergent BioSolutions Inc (EBS)

34.82
NYSE : Health Care
Prev Close 35.49
Day Low/High 34.68 / 35.59
52 Wk Low/High 24.47 / 36.95
Avg Volume 306.80K
Exchange NYSE
Shares Outstanding 41.21M
Market Cap 1.46B
EPS 1.30
P/E Ratio 24.31
Div & Yield N.A. (N.A)

Latest News

Emergent BioSolutions To Unveil Its Expanded Center For Innovation In Advanced Development And Manufacturing Supported Through Public-Private Partnership With BARDA

112,000-Square-Foot Baltimore Facility Is Designed to Enable Surge Manufacturing of Medical Countermeasures to Address Urgent Public Health Threats

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Emergent Biosolutions Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 19, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Emergent Biosolutions Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 19, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Emergent Biosolutions Inc.